MARKET

RMD

RMD

Resmed
NYSE
184.04
+0.94
+0.51%
After Hours: 184.38 +0.34 +0.18% 17:51 02/23 EST
OPEN
183.10
PREV CLOSE
183.10
HIGH
185.80
LOW
183.10
VOLUME
675.52K
TURNOVER
0
52 WEEK HIGH
243.52
52 WEEK LOW
131.49
MARKET CAP
27.07B
P/E (TTM)
30.49
1D
5D
1M
3M
1Y
5Y
Why Is ResMed (RMD) Down 1.7% Since Last Earnings Report?
NASDAQ · 2d ago
Got $1,000? Buy These Hot Growth Stocks Before They Take Off
You don't need a lot of money to start investing in these three growth stocks. ResMed, DexCom, and Coupang enjoy steady top-line growth. DexCom produces continuous glucose monitoring devices to help diabetes patients track their blood glucose levels. Coupang is one of the largest e-commerce retailers in Asia.
The Motley Fool · 3d ago
Here's Why Investors Should Retain ResMed (RMD) Stock for Now
NASDAQ · 5d ago
Weekly Report: what happened at RMD last week (0212-0216)?
Weekly Report · 6d ago
ResMed (RMD) to Treat Sleep Apnea With New AirCurve 11 (Revised)
NASDAQ · 02/16 15:26
Jerry McGinnis, a Pioneer of Sleep Medicine, Dies at Age 89 -- Journal Report
Jerry McGinnis founded Respironics in the mid-1980s. The company was an early leader in devices that relieve the miseries of sleep apnea. He died Jan. 25 at the age of 89. His company outraced rivals to win regulatory clearance for a bedside CPAP device.
The Wall Street Journal · 02/16 15:00
ResMed (RMD) to Treat Sleep Apnea With New AirCurve 11 Device
NASDAQ · 02/13 15:23
An Intrinsic Calculation For ResMed Inc. (NYSE:RMD) Suggests It's 30% Undervalued
ResMed Inc. (NYSE:RMD) is estimated to be 30% undervalued based on its current share price of US$185. ResMed's estimated fair value is US$264 based on 2 Stage Free Cash Flow to Equity. We will use the Discounted Cash Flow model to estimate the value of the company. The method is based on the expected future cash flows and is discounted to their present value.
Simply Wall St · 02/12 11:42
More
About RMD
ResMed Inc. is a holding company. The Company, through its subsidiaries, is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. The Company’s segments include Sleep and Respiratory Care and Software as a Service. SDB includes obstructive sleep apnea and other respiratory disorders that occur during sleep. Its cloud-based digital software health applications, along with its devices, are designed to provide connected care to improve patient outcomes. Its portfolio of products includes devices, diagnostic products, mask systems, headgear and other accessories, dental devices, and cloud-based software and informatics solutions. Its comprehensive out-of-hospital software platforms support the professionals and caregivers.

Webull offers Resmed Inc stock information, including NYSE: RMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RMD stock methods without spending real money on the virtual paper trading platform.